Monday, July 30, 2007

Diabetes drug should remain on market: advisers

From CTV News:
The widely used diabetes drug Avandia should remain on the market, U.S. government health advisers recommended Monday. They say evidence of an increased risk of heart attack from taking GlaxoSmithKline's Canadian-manufactured drug doesn't merit removal.

The nonbinding recommendation to the Food and Drug Administration came on a majority vote by the panel.

"We're being asked today to take a very draconian action based on studies that have very significant weaknesses and are inadequate for us to make that kind of decision," said Rebecca Killion, a Bowie, Md., diabetic and the panel's patient representative. ...more

No comments: